Functions of MAPR (membrane-associated progesterone receptor) family members as heme/steroid-binding proteins

Current Protein and Peptide Science

Volumn 13, Issue 7, 2012, Pages 687-696

  Kimura, Ikuo ^a   Nakayama, Yoshiaki ^b   Konishi, Morichika ^c   Terasawa, Kazuya ^a   Ohta, Mitsuhiro ^c   Itoh, Nobuyuki ^a   Fujimoto, Masafumi ^d  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO SANGYO UNIVERSITY   (Japan)

^c KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^d Nagaokai Neyagawa Sanatorium ^*  (Japan)

Author keywords

Heme binding protein; MAPR; Neudesin; Neuferricin; PGRMC1; PGRMC2

Indexed keywords

CYTOCHROME B5; HEMOPROTEIN; MEMBRANE ASSOCIATED PROGESTERONE RECEPTOR; NEUDESIN; NEUFERRICIN; PROGESTERONE RECEPTOR; STEROID BINDING PROTEIN; UNCLASSIFIED DRUG;

ADIPOGENESIS; AMINO ACID SEQUENCE; BIOLOGICAL ACTIVITY; CELL DIFFERENTIATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CHOLESTEROL SYNTHESIS; ENZYME REGULATION; GENE EXPRESSION; HUMAN; KNOCKOUT GENE; LIPID METABOLISM; MEMBRANE COMPONENT; NONHUMAN; PHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN STRUCTURE, FUNCTION AND VARIABILITY; REVIEW; SIGNAL TRANSDUCTION;

ADIPOGENESIS; ANIMALS; BINDING SITES; CENTRAL NERVOUS SYSTEM; CHOLESTEROL; GENE EXPRESSION REGULATION; HEME; HEMEPROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; PROTEIN BINDING; RECEPTORS, PROGESTERONE; SIGNAL TRANSDUCTION;

EID: 84874823951     PISSN: 13892037     EISSN: 18755550     Source Type: Journal    
DOI: 10.2174/138920312804142110     Document Type: Review

References (69)

1. Kimura, I.; Yoshioka, M.; Konishi, M.; Miyake, A.; Itoh, N. Neudesin, a novel secreted protein with a unique primary structure and neurotrophic activity. J. Neurosci. Res., 2005, 79, 287-294.
2. Kimura, I.; Nakayama, Y.; Konishi, M.; Kobayashi, T.; Mori, M.; Ito, M.; Hirasawa, A.; Tsujimoto, G.; Ohta, M.; Itoh, N.; Fujimoto, M. Neuferricin, a novel extracellular heme-binding protein, promotes neurogenesis. J. Neurochem., 2010, 112, 1156-1167.
3. Mifsud, W.; Bateman A. Membrane-bound progesterone receptors contain a cytochrome b5-like ligand-binding domain. Genome Biol., 2002, 3, 12.
4. Rohe, H. J.; Ahmed, I. S.; Twist, K. E.; Craven, R. J. Pgrmc1 (progesterone receptor membrane component 1): A targetable protein with multiple functions in steroid signaling, p450 activation and drug binding. Pharmacol. Ther., 2009, 121, 14-19.
5. Thomas, P. Characteristics of membrane progestin receptor alpha (mPR alpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions. Front Neuroendocrinol., 2008, 29, 292-312.
6. Burmester, T.; Weich, B.; Reinhardt, S.; Hankeln, T. A vertebrate globin expressed in the brain. Nature, 2000, 407, 520-523.
7. Black, S. M.; Harikrishna, J. A.; Szklarz, G. D.; Miller, W. L. The mitochondrial environment is required for activity of the cholesterol side-chain cleavage enzyme cytochrome P450scc. Proc. Natl. Acad. Sci. U. S. A., 1994, 91, 7247-7251.
8. Denninger, J. W.; Marletta, M. A. Guanylate cyclase and the NO/cGMP signaling pathway. Biochim. Biophys. Acta., 1999, 1411, 334-350.
9. Faller, M.; Matsunaga, M.; Yin, S.; Loo, J. A.; Guo, F. Heme is involved in microRNA processing. Nat. Struct. Mol. Biol., 2007, 14, 23-29.
10. Meyer, C.; Schmid, R.; Scriba, P. C.; Wehling, M. Purification and partial sequencing of high-affinity progesterone-binding site(s) from porcine liver membranes. Eur. J. Biochem., 1996, 239, 726-731.
11. Peluso, J. J.; Romak, J.; Liu, X. Progesterone receptor membrane component-1 (PGRMC1) is the mediator of progesterone's antiapoptotic action in spontaneously immortalized granulosa cells as revealed by PGRMC1 small interfering ribonucleic acid treatment and functional analysis of PGRMC1 mutations. Endocrinology, 2008, 149, 534-543.
12. Gerdes, D.; Wehling, M.; Leube, B.; Falkenstein, E. Cloning and tissue expression of two putative steroid membrane receptors. Biol. Chem., 1998, 379, 907-911.
13. Min, L.; Strushkevich, N. V.; Harnastai, I. N.; Iwamoto, H.; Gilep, A. A.; Takemori, H.; Usanov, S. A.; Nonaka, Y.; Hori, H.; Vinson, G. P.; Okamoto, M. Molecular identification of adrenal inner zone antigen as a heme-binding protein. FEBS J. 2005, 272, 5832-5843.
14. Ghosh, K.; Thompson, A. M.; Goldbeck, R. A.; Shi, X.; Whitman, S.; Oh, E.; Zhiwu, Z.; Vulpe, C.; Holman, T. R. Spectroscopic and biochemical characterization of heme binding to yeast Dap1p and mouse PGRMC1p. Biochemistry, 2005, 44, 16729-16736.
15. Crudden, G.; Chitti, R. E.; Craven, R. J. Hpr6 (heme-1 domain protein) regulates the susceptibility of cancer cells to chemotherapeutic drugs. J. Pharmacol. Exp. Ther., 2006, 316, 448-455.
16. Nakanishi, N.; Takeuchi, F.; Okamoto, H.; Tamura, A.; Hori, H.; Tsubaki, M. Characterization of heme-coordinating histidyl residues of cytochrome b5 based on the reactivity with diethylpyrocarbonate: a mechanism for the opening of axial imidazole rings. J. Biochem., 2006, 140, 561-571.
17. Neubauer, H.; Clare, S. E.; Wozny, W.; Schwall, G. P.; Poznanovic, S.; Stegmann, W.; Vogel, U.; Sotlar, K.; Wallwiener, D.; Kurek, R.; Fehm, T.; Cahill, M. A. Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1. Breast Cancer Res. 2008, 10, R85.
18. Hashimoto, K.; Ishiwata, K. Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals. Curr. Pharm. Des., 2006, 12, 3857-3876.
19. Xu, J.; Zeng, C.; Chu, W.; Pan, F.; Rothfuss, J. M.; Zhang, F.; Tu, Z.; Zhou, D.; Zeng, D.; Vangveravong, S.; Johnston, F.; Spitzer, D.; Chang, K. C.; Hotchkiss, R. S.; Hawkins, W. G.; Wheeler, K. T.; Mach, R. H. Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site. Nat. Commun., 2011, 2, 380.
20. Krebs, C. J.; Jarvis, E. D.; Chan, J.; Lydon, J. P.; Ogawa, S.; Pfaff, D. W. A membrane-associated progesterone-binding protein, 25-Dx, is regulated by progesterone in brain regions involved in female reproductive behaviors. Proc. Natl. Acad. Sci. U.S.A., 2000, 97, 12816-12821.
21. Selmin, O.; Lucier, G. W.; Clark, G. C.; Tritscher, A. M.; Van den Heuvel, J. P.; Gastel, J. A.; Walker, N. J.; Sutter, T. R.; Bell, D. A. Isolation and characterization of a novel gene induced by 2,3,7,8- tetrachlorodibenzo-p-dioxin in rat liver. Carcinogenesis, 1996, 17, 2609-2615.
22. Crudden, G.; Loesel, R.; Craven, R. J. Overexpression of the cytochrome p450 activator hpr6 (heme-1 domain protein/human progesterone receptor) in tumors. Tumour Biol., 2005, 26, 142-146.
23. Peluso, J. J.; Liu, X.; Saunders, M. M.; Claffey, K. P.; Phoenix, K. Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1. J. Clin. Endocrinol. Metab., 2008, 93, 1592-1599.
24. Difilippantonio, S.; Chen, Y.; Pietas, A.; Schlüns, K.; Pacyna- Gengelbach, M.; Deutschmann, N.; Padilla-Nash, H. M.; Ried, T.; Petersen, I. Gene expression profiles in human non-small and small-cell lung cancers. Eur. J. Cancer., 2003, 39, 1936-1947.
25. Dressman, H. K.; Hans, C.; Bild, A.; Olson, J. A.; Rosen, E.; Marcom, P. K.; Liotcheva, V. B.; Jones, E. L.; Vujaskovic, Z.; Marks, J.; Dewhirst, M. W.; West, M.; Nevins, J. R.; Blackwell, K. Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy. Clin. Cancer Res., 2006, 12, 819-826.
26. Irby, R. B.; Malek, R. L.; Bloom, G.; Tsai, J.; Letwin, N.; Frank, B. C.; Verratti, K.; Yeatman, T. J.; Lee, N. H. Iterative microarray and RNA interference-based interrogation of the SRC-induced invasive phenotype. Cancer Res., 2005, 65, 1814-1821.
27. Selmin, O.; Thorne, P. A.; Blachere, F. M.; Johnson, P. D.; Romagnolo, D. F. Transcriptional activation of the membranebound progesterone receptor (mPR) by dioxin, in endocrineresponsive tissues. Mol. Reprod. Dev., 2005, 70, 166-174.
28. Nilsson, E. E.; Stanfield, J.; Skinner, M. K. Interactions between progesterone and tumor necrosis factor-alpha in the regulation of primordial follicle assembly. Reproduction, 2006, 132, 877-886.
29. Cai, Z.; Stocco, C. Expression and regulation of progestin membrane receptors in the rat corpus luteum. Endocrinology, 2005, 146, 5522-5532.
30. Meffre, D.; Delespierre, B.; Gouézou, M.; Leclerc, P.; Vinson, G. P.; Schumacher, M.; Stein, D. G.; Guennoun, R. The membraneassociated progesterone-binding protein 25-Dx is expressed in brain regions involved in water homeostasis and is up-regulated after traumatic brain injury. J. Neurochem., 2005, 93, 1314-1326.
31. Sakamoto, H.; Ukena, K.; Takemori, H.; Okamoto, M.; Kawata, M.; Tsutsui, K. Expression and localization of 25-Dx, a membraneassociated putative progesterone-binding protein, in the developing Purkinje cell. Neuroscience, 2004, 126, 325-334.
32. Hughes, A. L.; Powell, D. W.; Bard, M.; Eckstein, J.; Barbuch, R.; Link, A. J.; Espenshade, P. J. Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes. Cell Metab., 2007, 5, 143-149.
33. Min, L.; Takemori, H.; Nonaka, Y.; Katoh, Y.; Doi, J.; Horike, N.; Osamu, H.; Raza, F. S.; Vinson, G. P.; Okamoto, M. Characterization of the adrenal-specific antigen IZA (inner zone antigen) and its role in the steroidogenesis. Mol. Cell. Endocrinol., 2004, 215, 143-148.
34. Suchanek, M.; Radzikowska, A.; Thiele, C. Photo-leucine and photo-methionine allow identification of protein-protein interactions in living cells. Nat. Methods., 2005, 2, 261-267.
35. Yang, T.; Espenshade, P. J.; Wright, M. E.; Yabe, D.; Gong, Y.; Aebersold, R.; Goldstein, J. L.; Brown, M. S. Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell, 2002, 110, 489-500.
36. Hand, R. A.; Craven, R. J. Hpr6.6 protein mediates cell death from oxidative damage in MCF-7 human breast cancer cells. J. Cell. Biochem., 2003, 90, 534-547.
37. Raza, F. S.; Takemori, H.; Tojo, H.; Okamato, M.; Vinson, G. P. Identification of the rat adrenal zona fasciculata/reticularis specifc protein, inner zone antigen (IZAg), as the putative membrane progesterone receptor. Eur. J. Biochem., 2001, 268, 2141-2147.
38. Mallory, J. C.; Crudden, G.; Johnson, B. L.; Mo, C.; Pierson, C. A.; Bard, M.; Craven, R. J. Dap1p, a heme-binding protein that regulates the cytochrome P450 protein Erg11p/Cyp51p in Saccharomyces cerevisiae. Mol. Cell. Biol., 2005, 25, 1669-1679.
39. Hand, R. A.; Jia, N.; Bard, M.; Craven, R. J. Saccharomyces cerevisiae Dap1p, a novel DNA damage response protein related to the mammalian membrane-associated progesterone receptor. Eukaryotic Cell, 2003, 2, 306-317.
40. Craven, R. J.; Mallory, J. C.; Hand, R. A. Regulation of iron homeostasis mediated by the heme-binding protein Dap1 (damage resistance protein 1) via the P450 protein Erg11/Cyp51. J. Biol. Chem., 2007, 282, 36543-36551.
41. Runko, E.; Kaprielian, Z. Expression of the Vema in the developing mouse spinal cord and optic chiasm. J. Comp. Neurol., 2002, 451, 289-299.
42. Cahill, M. A. Progesterone receptor membrane component 1: an integrative review. J. Steroid. Biochem. Mol. Biol., 2007, 105, 16-36.
43. Schumacher, M.; Guennoun, R.; Stein, D. G.; De Nicola, A. F. Progesterone: therapeutic opportunities for neuroprotection and myelin repair. Pharmacol. Ther., 2007, 116, 77-106.
44. Labombarda, F.; Gonzalez, S. L.; Deniselle, M. C.; Vinson, G. P.; Schumacher, M.; De Nicola, A. F.; Guennoun, R. Effects of injury and progesterone treatment on progesterone receptor and progesterone binding protein 25-Dx expression in the rat spinal cord. J. Neurochem., 2003, 87, 902-913.
45. Bashour, N. M.; Wray, S. Progesterone directly and rapidly inhibit GnRH neuronal activity via progesterone receptor membrane component 1. Endocrinology. 2012, 153, 4457-4469.
46. Thompson, A. M.; Reddi, A. R.; Shi, X.; Goldbeck, R. A.; Moënne-Loccoz, P.; Gibney, B. R.; Holman, T. R. Measurement of the heme affinity for yeast dap1p, and its importance in cellular function. Biochemistry, 2007, 46, 14629-14637.
47. Debose-Boyd, R. A. A helping hand for cytochrome p450 enzymes. Cell Metab., 2007, 5, 81-83.
48. Hand, R. A.; Craven, R. J. Hpr6.6 protein mediates cell death from oxidative damage in MCF-7 human breast cancer cells. J. Cell. Biochem., 2003, 90, 534-547.
49. Mir, S. U.; Ahmed, I. S.; Arnold, S.; Craven, R. J. Elevated progesterone receptor membrane component 1/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients. Int J Cancer. 2012, 131, E1-9.
50. Wei, S. H.; Balch, C.; Paik, H. H.; Kim, Y. S.; Baldwin, R. L.; Liyanarachchi, S.; Li, L.; Wang, Z.; Wan, J. C.; Davuluri, R. V.; Karlan, B. Y.; Gifford, G.; Brown, R.; Kim, S.; Huang, T. H.; Nephew, K. P. Prognostic DNA methylation biomarkers in ovarian cancer. Clin. Cancer Res., 2006, 12, 2788-2794.
51. Nie, A. Y.; McMillian, M.; Parker, J. B.; Leone, A.; Bryant, S.; Yieh, L.; Bittner, A.; Nelson, J.; Carmen, A.; Wan, J.; Lord, P. G. Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity. Mol. Carcinog., 2006, 45, 914-933.
52. Hokaiwado, N.; Asamoto, M.; Tsujimura, K.; Hirota, T.; Ichihara, T.; Satoh, T.; Shirai, T. Rapid analysis of gene expression changes caused by liver carcinogens and chemopreventive agents using a newly developed three-dimensional microarray system. Cancer Sci., 2004, 95, 123-130.
53. Nebert, D. W.; Bausserman, L. L. Genetic differences in the extent of aryl hydrocarbon hydroxylase induction in mouse fetal cell cultures. J. Biol. Chem., 1970, 245, 6373-6382.
54. Albro, P. W.; Corbett, J. T.; Harris, M.; Lawson, L. D. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on lipid profiles in tissue of the Fischer rat. Chem. Biol. Interact., 1978, 23, 315-330.
55. Kociba, R. J.; Keyes, D. G.; Beyer, J. E.; Carreon, R. M.; Wade, C. E.; Dittenber, D. A.; Kalnins, R. P.; Frauson, L. E.; Park, C. N.; Barnard, S. D.; Hummel, R. A.; Humiston, C. G. Results of a twoyear chronic toxicity and oncogenicity study of 2,3,7,8- tetrachlorodibenzo-p-dioxin in rats. Toxicol. Appl. Pharmacol., 1978, 46, 279-303.
56. Albrecht, C.; Huck, V.; Wehling, M.; Wendler, A. In vitro inhibition of SKOV-3 cell migration as a distinctive feature of progesterone receptor membrane component type 2 versus type 1.Steroids. 2012, Oct12, Epub ahead of print.
57. Liu, L.; Wang, J.; Zhao, L.; Nilsen, J.; McClure, K.; Wong, K.; Brinton, R. D. Progesterone increases rat neural progenitor cell cycle gene expression and proliferation via extracellularly regulated kinase and progesterone receptor membrane components 1 and 2. Endocrinology, 2009, 150, 3186-3196.
58. Skiadas, C. C.; Duan, S.; Correll, M.; Rubio, R.; Karaca, N.; Ginsburg, E. S.; Quackenbush, J.; Racowsky, C. Ovarian reserve status in young women is associated with altered gene expression in membrana granulosa cells. Mol. Hum. Reprod., 2012, 18, 362-371.
59. Keator, C. S.; Mah, K.; Slayden, O. D. Alterations in progesterone receptor membrane component 2 (pgrmc2) in the endometrium of macaques afflicted with advanced endometriosis. Mol. Hum. Reprod., 2012, 18, 308-319.
60. Kimura, I.; Nakayama, Y.; Yamauchi, H.; Konishi, M.; Miyake, A.; Mori, M.; Ohta, M.; Itoh, N.; Fujimoto, M. Neurotrophic activity of neudesin, a novel extracellular heme-binding protein, is dependent on the binding of heme to its cytochrome b5-like heme/steroid-binding domain. J. Biol. Chem., 2008, 283, 4323-4331.
61. Kimura, I.; Konishi, M.; Miyake, A.; Fujimoto, M.; Itoh, N. Neudesin, a secreted factor, promotes neural cell proliferation and neuronal differentiation in mouse neural precursor cells. J. Neurosci. Res., 2006, 83, 1415-1424.
62. Kimura, I.; Konishi, M.; Asaki, T.; Furukawa, N.; Ukai, K.; Mori, M.; Hirasawa, A.; Tsujimoto, G.; Ohta, M.; Itoh, N.; Fujimoto, M.; Neudesin, an extracellular heme-binding protein, suppresses adipogenesis in 3T3-L1 cells via the MAPK cascade. Biochem. Biophys. Res. Commun., 2009, 381, 75-80.
63. Koutnikova, H.; Auwerx, J. Regulation of adipocyte differentiation. Ann. Med., 2001, 33, 556-561.
64. Fisher, B.; Jeong, J. H.; Dignam, J.; Anderson, S.; Mamounas, E.; Wickerham, D. L.; Wolmark, N. Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stageI breast cancer. J. Nastl. Cancer Inst. Monogr., 2001, 62-66
65. Neubauer, H.; Clare, S. E.; Kurek, R.; Fehm, T.; Wallwiener, D.; Sotlar, K.; Nordheim, A.; Wozny, W.; Schwall, G. P.; Poznanovi-, S.; Sastri, C.; Hunzinger, C.; Stegmann, W.; Schrattenholz, A.; Cahill, M. A. Breast cancer proteomics by laser capture microdissection sample pooling 54-cm IPG IEF and differential iodine radioisotope detection. Electrophoresis, 2006, 27, 1840-1852
66. Ma, L.; Broomfield, S.; Lavery, C.; Lin, S. L.; Xiao, W.; Bacchetti, S. Up-regulation of CIR1/CROC1 expression upon cell immortalization and in tumor-derived human cell lines. Oncogene, 1998, 17, 1321-1326.
67. Han, K. H.; Lee, S. H.; Ha, S. A.; Kim, H. K.; Lee, C.; Kim, D. H.; Gong, K. H.; Yoo, J.; Kim, S.; Kim, J. W. The functional and structural characterization of a novel oncogene GIG47 involved in the breast tumorigenesis. BMC Cancer. 2012, July 2, Epub ahead of print.
68. Xie, Y.; Bruce, A.; He, L.; Wei, F.; Tao, L.; Tang, D. Cyb5d2 enhances hela cells survival of etoposide-induced cytotoxicity. Biochem. Cell Biol., 2011, 89, 341-350.
69. Batista, L. F.; Kaina, B.; Meneghini, R.; Menck, C. F. How DNA lesions are turned into powerful killing structures: Insights from uv-induced apoptosis. Mutat. Res., 2009, 681, 197-208.